Table of Contents

1 Industry Overview

• 1.1 Erlotinib Hydrochloride Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Erlotinib Hydrochloride
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Erlotinib Hydrochloride Market by Type

• 3.1 By Type
  • 3.1.1 25mg
  • 3.1.2 100mg
  • 3.1.3 150mg
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Erlotinib Hydrochloride Roche (Company Profile, Sales Data etc.)

• 4.2 Cipla (Company Profile, Sales Data etc.)
• 4.3 Mylan (Company Profile, Sales Data etc.)
• 4.4 Teva (Company Profile, Sales Data etc.)
• 4.5 OSI Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.6 Glenmark Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.7 Beacon Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.8 Raichem Lifesciences (Company Profile, Sales Data etc.)
• 4.9 United Biotech (Company Profile, Sales Data etc.)
• 4.10 CJ Corporation (Company Profile, Sales Data etc.)
• 4.11 Vivimed Labs (Company Profile, Sales Data etc.)
• 4.12 Boryung Pharmaceutical (Company Profile, Sales Data etc.)
• 4.13 Taj Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.14 Pharmascience (Company Profile, Sales Data etc.)
• 4.15 Natco Pharma (Company Profile, Sales Data etc.)
• 4.16 Intas Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.17 RPG Life Sciences (Company Profile, Sales Data etc.)
• 4.18 Pharmascience (Company Profile, Sales Data etc.)
• 4.19 Schwarz Pharma (Company Profile, Sales Data etc.)
• 4.20 Dr. Reddy’s Laboratories (Company Profile, Sales Data etc.)
• 4.21 Glenmark Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.22 Chugai Pharmaceutical (Company Profile, Sales Data etc.)
• 4.23 DKSH (Company Profile, Sales Data etc.)
• 4.24 Firma Chun Cheong (Company Profile, Sales Data etc.)
• 4.25 Kremers Urban Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.26 Ortat (Company Profile, Sales Data etc.)
• 4.27 Zuellig Pharma (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Non-small Cell Lung Cancer
  • 6.1.2 Demand in Pancreatic Cancer
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Erlotinib Hydrochloride

Table Application Segment of Erlotinib Hydrochloride

Table Global Erlotinib Hydrochloride Market 2013-2024, by Application, in USD Million

Table Major Company List of 25mg

Table Major Company List of 100mg

Table Major Company List of 150mg

Table Global Erlotinib Hydrochloride Market 2013-2018, by Type, in USD Million

Table Global Erlotinib Hydrochloride Market 2013-2018, by Type, in Volume

Table Global Erlotinib Hydrochloride Market Forecast 2019-2024, by Type, in USD Million

Table Global Erlotinib Hydrochloride Market Forecast 2019-2024, by Type, in Volume

Table Roche Overview List

Table Erlotinib Hydrochloride Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cipla Overview List

Table Erlotinib Hydrochloride Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Mylan Overview List

Table Erlotinib Hydrochloride Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teva Overview List

Table Erlotinib Hydrochloride Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table OSI Pharmaceuticals Overview List

Table Erlotinib Hydrochloride Business Operation of OSI Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Glenmark Pharmaceuticals Overview List

Table Erlotinib Hydrochloride Business Operation of Glenmark Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Beacon Pharmaceuticals Overview List

Table Erlotinib Hydrochloride Business Operation of Beacon Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Raichem Lifesciences Overview List

Table Erlotinib Hydrochloride Business Operation of Raichem Lifesciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table United Biotech Overview List

Table Erlotinib Hydrochloride Business Operation of United Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CJ Corporation Overview List

Table Erlotinib Hydrochloride Business Operation of CJ Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Vivimed Labs Overview List

Table Erlotinib Hydrochloride Business Operation of Vivimed Labs (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Boryung Pharmaceutical Overview List

Table Erlotinib Hydrochloride Business Operation of Boryung Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Taj Pharmaceuticals Overview List

Table Erlotinib Hydrochloride Business Operation of Taj Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pharmascience Overview List

Table Erlotinib Hydrochloride Business Operation of Pharmascience (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Natco Pharma Overview List

Table Erlotinib Hydrochloride Business Operation of Natco Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Intas Pharmaceuticals Overview List

Table Erlotinib Hydrochloride Business Operation of Intas Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table RPG Life Sciences Overview List

Table Erlotinib Hydrochloride Business Operation of RPG Life Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pharmascience Overview List

Table Erlotinib Hydrochloride Business Operation of Pharmascience (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Schwarz Pharma Overview List

Table Erlotinib Hydrochloride Business Operation of Schwarz Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Dr. Reddy’s Laboratories Overview List

Table Erlotinib Hydrochloride Business Operation of Dr. Reddy’s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Glenmark Pharmaceuticals Overview List

Table Erlotinib Hydrochloride Business Operation of Glenmark Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Chugai Pharmaceutical Overview List

Table Erlotinib Hydrochloride Business Operation of Chugai Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table DKSH Overview List

Table Erlotinib Hydrochloride Business Operation of DKSH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Firma Chun Cheong Overview List

Table Erlotinib Hydrochloride Business Operation of Firma Chun Cheong (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Kremers Urban Pharmaceuticals Overview List

Table Erlotinib Hydrochloride Business Operation of Kremers Urban Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Ortat Overview List

Table Erlotinib Hydrochloride Business Operation of Ortat (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Zuellig Pharma Overview List

Table Erlotinib Hydrochloride Business Operation of Zuellig Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Erlotinib Hydrochloride Sales Revenue 2013-2018, by Company, in USD Million

Table Global Erlotinib Hydrochloride Sales Revenue Share, by Company, in USD Million

Table Global Erlotinib Hydrochloride Sales Volume 2013-2018, by Company, in Volume

Table Global Erlotinib Hydrochloride Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Erlotinib Hydrochloride Demand Forecast 2019-2024, by Application, in USD Million

Table Erlotinib Hydrochloride Demand Forecast 2019-2024, by Application, in Volume

Table Erlotinib Hydrochloride Production 2013-2018, by Region, in USD Million

Table Erlotinib Hydrochloride Production 2013-2018, by Region, in Volume

Table Global Erlotinib Hydrochloride Market 2013-2018, by Region, in USD Million

Table Global Erlotinib Hydrochloride Market Share 2013-2018, by Region, in USD Million

Table Global Erlotinib Hydrochloride Market 2013-2018, by Region, in Volume

Table Global Erlotinib Hydrochloride Market Share 2013-2018, by Region, in Volume

Table North America Erlotinib Hydrochloride Market Size 2013-2018, by Country, in USD Million

Table North America Erlotinib Hydrochloride Market Size 2013-2018, by Country, in Volume

Table Europe Erlotinib Hydrochloride Market Size 2013-2018, by Country, in USD Million

Table Europe Erlotinib Hydrochloride Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Erlotinib Hydrochloride Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Erlotinib Hydrochloride Market Size 2013-2018, by Country, in Volume

Table South America Erlotinib Hydrochloride Market Size 2013-2018, by Country, in USD Million

Table South America Erlotinib Hydrochloride Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Erlotinib Hydrochloride Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Erlotinib Hydrochloride Market Size 2013-2018, by Country, in Volume

Table Erlotinib Hydrochloride Market Forecast 2019-2024, by Region, in USD Million

Table Erlotinib Hydrochloride Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Erlotinib Hydrochloride Market Growth 2013-2018, by Type, in USD Million

Figure Global Erlotinib Hydrochloride Market Growth 2013-2018, by Type, in Volume

Figure North America Erlotinib Hydrochloride Market Concentration, in 2018

Figure Europe Erlotinib Hydrochloride Market Market Concentration, in 2018

Figure Asia-Pacific Erlotinib Hydrochloride MMarket Concentration, in 2018

Figure South America Erlotinib Hydrochloride Market Concentration, in 2018

Figure Middle East & Africa Erlotinib Hydrochloride Market Concentration, in 2018

Figure Erlotinib Hydrochloride Demand in Non-small Cell Lung Cancer, 2013-2018, in USD Million

Figure Erlotinib Hydrochloride Demand in Non-small Cell Lung Cancer, 2013-2018, in Volume

Figure Erlotinib Hydrochloride Demand in Pancreatic Cancer, 2013-2018, in USD Million

Figure Erlotinib Hydrochloride Demand in Pancreatic Cancer, 2013-2018, in Volume

Figure North America Erlotinib Hydrochloride Market Size and Growth 2013-2018, in USD Million

Figure North America Erlotinib Hydrochloride Market Size and Growth 2013-2018, in Volume

Figure Europe Erlotinib Hydrochloride Market Size and Growth 2013-2018, in USD Million

Figure Europe Erlotinib Hydrochloride Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Erlotinib Hydrochloride Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Erlotinib Hydrochloride Market Size and Growth 2013-2018, in Volume

Figure South America Erlotinib Hydrochloride Market Size and Growth 2013-2018, in USD Million

Figure South America Erlotinib Hydrochloride Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Erlotinib Hydrochloride Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Erlotinib Hydrochloride Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview

Snapshot
Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells and slows their spread in the body
The global Erlotinib Hydrochloride market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Erlotinib Hydrochloride by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
25mg
100mg
150mg
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Roche
Cipla
Mylan
Teva
OSI Pharmaceuticals
Glenmark Pharmaceuticals
Beacon Pharmaceuticals
Raichem Lifesciences
United Biotech
CJ Corporation
Vivimed Labs
Boryung Pharmaceutical
Taj Pharmaceuticals
Pharmascience
Natco Pharma
Intas Pharmaceuticals
RPG Life Sciences
Pharmascience
Schwarz Pharma
Dr. Reddy’s Laboratories
Glenmark Pharmaceuticals
Chugai Pharmaceutical
DKSH
Firma Chun Cheong
Kremers Urban Pharmaceuticals
Ortat
Zuellig Pharma
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Non-small Cell Lung Cancer
Pancreatic Cancer
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)